JP2024507414A5 - - Google Patents

Info

Publication number
JP2024507414A5
JP2024507414A5 JP2023575684A JP2023575684A JP2024507414A5 JP 2024507414 A5 JP2024507414 A5 JP 2024507414A5 JP 2023575684 A JP2023575684 A JP 2023575684A JP 2023575684 A JP2023575684 A JP 2023575684A JP 2024507414 A5 JP2024507414 A5 JP 2024507414A5
Authority
JP
Japan
Prior art keywords
ring
membered
group
pharmaceutical composition
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507414A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/017312 external-priority patent/WO2022178420A1/en
Publication of JP2024507414A publication Critical patent/JP2024507414A/ja
Publication of JP2024507414A5 publication Critical patent/JP2024507414A5/ja
Pending legal-status Critical Current

Links

JP2023575684A 2021-02-22 2022-02-22 ウイルス感染症治療のためのrock2阻害剤 Pending JP2024507414A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163152260P 2021-02-22 2021-02-22
US63/152,260 2021-02-22
PCT/US2022/017312 WO2022178420A1 (en) 2021-02-22 2022-02-22 Rock2 inhibitor for the treatment of viral infection

Publications (2)

Publication Number Publication Date
JP2024507414A JP2024507414A (ja) 2024-02-19
JP2024507414A5 true JP2024507414A5 (cg-RX-API-DMAC7.html) 2025-02-26

Family

ID=82931820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575684A Pending JP2024507414A (ja) 2021-02-22 2022-02-22 ウイルス感染症治療のためのrock2阻害剤

Country Status (8)

Country Link
US (1) US20240165116A1 (cg-RX-API-DMAC7.html)
EP (1) EP4301132A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024507414A (cg-RX-API-DMAC7.html)
KR (1) KR20240009918A (cg-RX-API-DMAC7.html)
CN (1) CN117529320A (cg-RX-API-DMAC7.html)
AU (1) AU2022224669A1 (cg-RX-API-DMAC7.html)
CA (1) CA3209240A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022178420A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202327608A (zh) * 2021-09-17 2023-07-16 北京泰德製藥股份有限公司 治療病毒感染的方法
CA3231781A1 (en) * 2021-09-18 2023-03-23 Beijing Tide Pharmaceutical Co., Ltd. Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereof
US12637461B2 (en) 2022-10-18 2026-05-26 Pfizer Inc. Compounds for the activation of AMPK
WO2024220173A1 (en) * 2023-04-18 2024-10-24 Genosco Inc. Blood brain barrier penetrating selective inhibitors of rock2 protein kinases and uses thereof
EP4698528A1 (en) * 2023-04-18 2026-02-25 Genosco Inc. Selective inhibitors of rock2 protein kinases and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470137A (en) * 1967-02-14 1969-09-30 Du Pont Inter se copolymers of bicyclo(1.1.0)butanes
WO2015025172A1 (en) * 2013-08-22 2015-02-26 Mark David Charles 5-aryl-thiazol-2-yl-amine compounds and their therapeutic use
CA3155220C (en) * 2016-03-02 2024-01-16 Gilead Apollo, Llc Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof
EP3308786A1 (en) * 2016-10-13 2018-04-18 ETH Zurich Fgfr regulaton for the treatment of viral infections
JP6593305B2 (ja) * 2016-11-09 2019-10-23 株式会社村田製作所 二次電池用電解液、二次電池、電池パック、電動車両、電力貯蔵システム、電動工具および電子機器
JP7311228B2 (ja) * 2017-06-30 2023-07-19 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
TWI804743B (zh) * 2019-06-25 2023-06-11 大陸商北京泰德製藥股份有限公司 治療特發性肺纖維化的方法
CN118772118A (zh) * 2020-08-31 2024-10-15 北京泰德制药股份有限公司 Rho相关蛋白激酶抑制剂的盐、其固体形式及其制备方法和用途
CA3231781A1 (en) * 2021-09-18 2023-03-23 Beijing Tide Pharmaceutical Co., Ltd. Solid form of rho-associated protein kinase inhibitor or solvate thereof, preparation method and use thereof
EP4434513A4 (en) * 2021-11-16 2025-11-19 Beijing Tide Pharmaceutical Co Ltd NANOCRYSTALLINE PREPARATION OF ROCK2 INHIBITOR AND ITS PREPARATION PROCESS
EP4561579A1 (en) * 2022-07-27 2025-06-04 Graviton Bioscience BV Rock2 inhibitors for the treatment of viral infections

Similar Documents

Publication Publication Date Title
JP2008509187A5 (cg-RX-API-DMAC7.html)
JP2004525179A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2021512150A5 (cg-RX-API-DMAC7.html)
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
RU2005113168A (ru) Производные 2-пиридона в качестве ингибитора нейтрофильной эластазы
RU2007108861A (ru) Трифтометилзамещенные бензамиды в качестве ингибиторов киназ
RU2003132687A (ru) Лечение диабета типа 2 ингибиторами дипептидилпептидазы iv
RU2006134020A (ru) Конденсированные производные пиразола
JP2016538313A5 (cg-RX-API-DMAC7.html)
JP2004534774A5 (cg-RX-API-DMAC7.html)
JP2022522486A5 (cg-RX-API-DMAC7.html)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
RU2005120780A (ru) Соединения с конденсированным 1,3-дигидроимидазольным циклом
JP2001526218A5 (cg-RX-API-DMAC7.html)
RU2003115612A (ru) Производные амидоалкилпиперидинов и амидоалкилпиперазинов, пригодные для лечения нарушений нервной системы
JP2008508214A (ja) 女性の性障害の治療用ピペラジン誘導体
IL205501A (en) Preparation of preparations for the treatment of arthritis
JP2008514732A5 (cg-RX-API-DMAC7.html)
JP2009507896A5 (cg-RX-API-DMAC7.html)
JP2006515339A5 (cg-RX-API-DMAC7.html)
JP2022119852A5 (cg-RX-API-DMAC7.html)
JP2005511594A5 (cg-RX-API-DMAC7.html)
JP2004525183A5 (cg-RX-API-DMAC7.html)